Clinical Trials in Colorado

Showing 4781-4800 of 13,761 trials

Coaching for Advanced Practice Providers

NCT05938556

This study aims to determine if online coaching is feasible in advanced practice providers (APP) and can impact burnout. The study will recruit APPs from Children's Healthcare of Atlanta (CHOA), Emory, Colorado University (CU), and their affiliate hospitals through online consent sent via email. Interventions will include online video coaching, written coaching, and self-coaching through self-study material.

Burnout, Professional

Emory University319 participantsStarted Jul 2023

Denver, Colorado, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +1 more locations

COMPLETEDPhase 253 miles

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

NCT03582137

The major purpose of this study is to assess the efficacy of CBD on motor symptoms of Parkinson's Disease (PD), and secondarily to study the safety and tolerability of CBD and other efficacy, particularly regarding tremor in PD. The study has been powered to detect a clinically significant reduction in Movement Disorder Society (MDS) Unified Parkinson's Disease Rating Scale (UPDRS) Part III motor scores. This is a 1:1 parallel, double-blind, randomized controlled trial (RCT) with 60 participants. The investigators will be recruiting up to 75 participants; the goal is to have 60 participants (30 in CBD group and 30 in placebo group) complete the study. The study drug is obtained from the National Institute on Drug Abuse (NIDA).

Parkinson Disease

University of Colorado, Denver74 participantsStarted Sep 2018

Aurora, Colorado, United States

Coaching for Advanced Practice Providers

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

Find Trials by Condition in Colorado

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Pediatric Medication Therapy Management Trial

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

Oral Nutritional Supplementation in Children at Risk of Undernutrition

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

Belimumab Assessment of Safety in SLE

Feasibility Study on LITT for Medical Refractory Epilepsy

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease